Business

Baird Medical to Showcase Minimally Invasive Thyroid Solutions at Upcoming US Clinical Conferences

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation for three major clinical conferences this quarter. These events are pivotal to the company's expansion, providing U.S. clinicians direct access to its innovative needle-based therapies for thyroid conditions.

articleBaird Medical Investment Holdings LtdFebruary 19, 20265/company/baird-medical-investment-holdings-limited/news/baird-medical-to-showcase-minimally-invasive-thyroid-solutions-at-upcoming-us-clinical-conferences
Baird Medical to Showcase Minimally Invasive Thyroid Solutions at Upcoming US Clinical Conferences

About this update from Baird Medical Investment Holdings Ltd

[{"type":"text","content":"NEW YORK, Feb. 19, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation for three major clinical conferences this quarter. These events are pivotal to the company's expansion, providing U.S. clinicians direct access to its innovative needle-based therapies for thyroid conditions.","length":471,"tagName":"p"},{"type":"image","alt":"Baird Medical (PRNewsfoto/Baird Medical LLC)","displaySize":"","headline":null,"caption":"Baird Medical (PRNewsfoto/Baird Medical LLC)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":58,"url":"https://media.zenfs.com/en/prnewswire.com/89184118f4af4c585e7c535395abe2bc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/0DcKXI1awHhZus7cyztYjQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTEwMjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/89184118f4af4c585e7c535395abe2bc","width":400,"height":58}},"href":"https://mma.prnewswire.com/media/2539350/Baird_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Baird Medical will join top interventionalists and surgeons to demonstrate how its proprietary technology treats benign nodules without the need for traditional surgery or scarring.","length":181,"tagName":"p"},{"type":"text","content":"The Company will present its solutions at:","length":42,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"North American Society for Interventional Endocrinology (NASOIE)","length":64,"tagName":"p"}]},{"val":[{"type":"text","content":"North American Society for Interventional Thyroidology (NASIT)","length":62,"tagName":"p"}]},{"val":[{"type":"text","content":"International Society of Innovative Technologies for Endocrine Surgery (ISITES)","length":79,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":205,"olType":false},{"type":"text","content":""We are on the ground at these events to show physicians exactly what our technology can do for their patients," said Mark Saxton, CEO of Baird Medical (US). "As minimally invasive options become the standard of care, building these direct relationships with the clinical community is how we drive adoption and grow our presence in the US mark...

More updates from Baird Medical Investment Holdings Ltd

Baird MedicalBaird Medical Investment Holdings Ltd.minimally invasiveForward-Looking Statementsthe companymedical device companyBaird Medical Investment Holdings LtdWeill Cornell Medical CenterTulane Medical CenterNorth American Societyproprietary technology